Revolution Medicines, Inc. (RVMD) — Analyst estimates
Consensus analyst estimates for Revolution Medicines, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 77.50M | -1.75 | 5 |
| 2027 | 323.9M | -0.94 | 5 |
| 2028 | 179.98M | -1.68 | 9 |
| 2029 | 3.61B | 3.86 | 10 |
| 2030 | 5.55B | 9.75 | 6 |
Consensus analyst estimates by fiscal year.